FINEPOINT CAPITAL LP

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Solid Biosciences Inc.
SLDB
$12.8M2.51961,2510%+$02.32
Travere Therapeutics, Inc.
TVTX
$12.72M2.171.65M+14.9%+$1.65M2.31
Liberty Broadband Corporation
LBRDK
$107.95M1.321.89M+922.59%+$97.39M19.58
EyePoint Pharmaceuticals, Inc.
EYPT
$13.57M1.26656,600New+$13.57M2.46
Relay Therapeutics, Inc.
RLAY
$12.37M1.121.49M+13.07%+$1.43M2.24
SpringWorks Therapeutics, Inc.
SWTX
$29.16M0.8592,528+6.39%+$1.75M5.29
Arvinas, Inc.
ARVN
$22.25M0.79539,100+6.82%+$1.42M4.04
Galapagos NV
GLPG
$16.22M0.76503,759+9.83%+$1.45M2.94
Prothena Corporation plc
PRTA
$9.97M0.75402,400+15.2%+$1.32M1.81
Churchill Capital Corp VII
CVII
$175.36M0.6548,0000%+$031.8
MoonLake Immunotherapeutics
MLTX
$18.13M0.57360,916-59.67%-$26.83M3.29
ACADIA Pharmaceuticals Inc.
ACAD
$15.54M0.51840,453+9.2%+$1.31M2.82
Revolution Medicines, Inc.
RVMD
$21.82M0.41677,100+9.72%+$1.93M3.96
Ascendis Pharma A/S
ASND
$26.56M0.3175,672+7.27%+$1.8M4.82
Calidi Biotherapeutics, Inc.
CLDI
$70,625.000.25125,0000%+$00.01
Cytokinetics, Incorporated
CYTK
$16.69M0.21238,046-44.86%-$13.58M3.03
Sarepta Therapeutics, Inc.
SRPT
$20.51M0.17158,457+9.01%+$1.7M3.72
argenx SE
ARGX
$19.69M0.0850,000New+$19.69M3.57